Axplora- The partner of choice for complex APIs.
01 1Farmabios S.p.A.
02 1Symbiotec Pharmalab Private Limited
03 1Aarti Pharmalabs Limited
04 1Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
05 1MEDISCA Inc.
06 1NEWCHEM SPA
07 1Professional Compounding Centers of America dba PCCA
08 1SYMBIOTICA SPECIALITY INGREDIENTS SDN.BHD
09 1Sicor S.r.l.
01 2DESONIDE
02 2DESONIDE MICRONIZED
03 4Desonide
04 1Desonide Micronized
01 1China
02 1Germany
03 2India
04 2Italy
05 1Malaysia
06 1U.S.A
07 1United Kingdom
Axplora- The partner of choice for complex APIs.
NDC Package Code : 46439-8713
Start Marketing Date : 1992-03-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
NDC Package Code : 22552-0046
Start Marketing Date : 2017-03-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0713
Start Marketing Date : 1983-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51508-009
Start Marketing Date : 2021-05-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3043
Start Marketing Date : 2017-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24002-0014
Start Marketing Date : 2009-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-4966
Start Marketing Date : 2016-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 53183-0317
Start Marketing Date : 2015-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52128-157
Start Marketing Date : 2013-11-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Desonide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desonide, including repackagers and relabelers. The FDA regulates Desonide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desonide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desonide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desonide supplier is an individual or a company that provides Desonide active pharmaceutical ingredient (API) or Desonide finished formulations upon request. The Desonide suppliers may include Desonide API manufacturers, exporters, distributors and traders.
click here to find a list of Desonide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Desonide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Desonide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Desonide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Desonide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Desonide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Desonide suppliers with NDC on PharmaCompass.
We have 9 companies offering Desonide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
